TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis (Q34121045)

31 July 2017

0 references

TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis (English)

1 reference

31 July 2017

1 reference

De-Ke Jiang

1

1 reference

31 July 2017

Lei Yao

2

1 reference

31 July 2017

Wei-Hua Ren

3

1 reference

31 July 2017

Wen-Zhang Wang

4

1 reference

31 July 2017

Bo Peng

5

1 reference

31 July 2017

Long Yu

6

1 reference

31 July 2017

publication date

15 June 2010

1 reference

31 July 2017

1 reference

31 July 2017

volume

28

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

1129-1135

1 reference

Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Obesity and gynaecological cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Hormonal carcinogenesis and socio-biological development factors in endometrial cancer: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Single nucleotide polymorphism: a new risk factor for endometrial cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Genetic polymorphisms and endometrial cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

P53 is a tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Shaping genetic alterations in human cancer: the p53 mutation paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

p53 polymorphisms: cancer implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Primary structure polymorphism at amino acid residue 72 of human p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Two polymorphic variants of wild-type p53 differ biochemically and biologically

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

The codon 72 polymorphic variants of p53 have markedly different apoptotic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

P53 codon 72 polymorphism and correlation with ovarian and endometrial cancer in Greek women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Association of p73 G4C14-to-A4T14 polymorphism at exon 2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Germline polymorphism of p53 codon 72 in gynecological cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Polymorphisms of p53 codon 72 and MDM2 promoter 309 and the risk of endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

The p53 codon 72 exon 4 BstUI polymorphism and endometrial cancer in Caucasian women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Why sources of heterogeneity in meta-analysis should be investigated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Explaining heterogeneity in meta-analysis: a comparison of methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

A method for meta-analysis of molecular association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Undetected genotyping errors cause apparent overtransmission of common alleles in the transmission/disequilibrium test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Detection of genotyping errors by Hardy-Weinberg equilibrium testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Systematic review of the empirical evidence of study publication bias and outcome reporting bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Hardy–Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations and power

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Impact of Violations and Deviations in Hardy-Weinberg Equilibrium on Postulated Gene-Disease Associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9597-X

Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case-control studies

1 reference

12 December 2020

Polymorphisms of the p53 gene in women with ovarian or endometrial carcinoma.

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review

1 reference

12 December 2020

10.1007/S12032-010-9597-X

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1042814188

0 references

1 reference